Anda di halaman 1dari 21

Renub Research

www.renub.com
Influenza Vaccines Market & Forecast Worldwide Analysis

United StatesJapanChinaIndia
BrazilNetherlandsGermanyFrance
ItalySpainDenmarkSwedenPortugal
LuxembourgLithuaniaUnited Kingdom
PolandNorwayRomaniaEstonia
FinlandHungaryIrelandIceland
LatviaMaltaSlovakiaSlovenia
New ZealandAustralia

Published: November, 2014


Renub Research

Page 1 of 21

Copyright 2014 Renub Research All Rights Reserved

Influenza Vaccines Market Analysis


The Influenza vaccines market represent an attractive market characterize by sturdy growth
prospects. Increasing awareness, growing vaccination coverage in the emerging countries,
rising government support for immunization against Seasonal Influenza and increased focus on
the production of treatments for vulnerable populations by introducing new vaccines and
vaccines with a better route of administration are the main drivers to galvanized Influenza
vaccines market.
Seasonal Influenza vaccines market has Billions US$ market in 2013. Seasonal Influenza
vaccines market is expected to grow with double digit percentage from 2013 to 2019. On the
other hand, H1N1 Influenza vaccines market has seen tremendous growth during 2009 and 2010
primarily driven by the global spread of H1N1 Influenza virus. However, strong demand of
Influenza vaccines contracted in 2011 by more than 50% due to waning threat of swine flu
epidemic.
United States remains the largest market for Seasonal Influenza vaccines. Japan and emerging
countries like China, India and Brazil is likely to drive Influenza vaccines markets in the next 5
to 6 years. Netherlands and United Kingdom have achieved greater vaccinations coverage.
In the major Seasonal Influenza vaccines sales segment, Fluzone (Sanofi Pasteur) has the
highest sales figures and likely to maintain leadership position in the Seasonal Influenza
vaccines market.
Renub

Research study

titled Influenza Vaccines

Market

& Forecast

Worldwide

Analysis provides a comprehensive assessment of the fast-evolving, high-growth of World


Influenza Vaccines Landscape. This 179 page report with 140 Figures and 7 Tables examines
the following segments for Influenza Vaccines Market

Worldwide Influenza vaccines market (2009 - 2019)

Worldwide Seasonal Influenza vaccines market has been covered from (2009 2019)

Renub Research

Page 2 of 21

Worldwide Swine Flu (H1N1) Influenza vaccines market has been covered from (2009
2011)

Worldwide number of persons being vaccinated with Seasonal Influenza vaccines (2009 2019)

Top 30 countries number of persons being vaccinated with Seasonal Influenza vaccines
(2009 - 2019)

Top 30 countries Seasonal Influenza vaccines market (2008 2019)

Top

Brands

Seasonal

Influenza

vaccines

(Fluarix/Flulaval,

Afluria/Fluvax,

FluMist/Fluenz, Influvac, Fluvirin / Flucelvax, Fluzone) Sales Performance & Forecast

Top Merger & Acquisition deals in Influenza Vaccines Market

Key drivers of growth in the Worldwide Influenza Vaccines Market

Key challenges faces by Influenza Vaccines Market

All the 30 Countries Studied in the Report are as Follows


1. United States

11. Denmark

21. Finland

2. Japan

12. Sweden

22. Hungary

3. China

13. Portugal

23. Ireland

4. India

14. Luxembourg

24. Iceland

5. Brazil

15. Lithuania

25. Latvia

6. Netherlands

16. United Kingdom

26. Malta

7. Germany

17. Poland

27. Slovakia

8. France

18. Norway

28. Slovenia

9. Italy

19. Romania

29. Australia

10. Spain

20. Estonia

30. New Zealand

Renub Research

Page 3 of 21

Top 6 Seasonal Influenza Vaccines Sales Performance Studied in the Report are as Follows

1. Fluarix / Flulaval
2. Afluria/Fluvax
3. FluMist/Fluenz
4. Influvac
5. Fluvirin / Flucelvax
6. Fluzone

Data Sources
This report is built using data and information sourced from proprietary databases, primary and
secondary research and in-house analysis by Renub Research team of industry experts. Primary
sources include industry surveys and telephone interviews with industry experts.
Secondary sources information and data has been collected from various printable and nonprintable sources like search engines, News websites, Government Websites, Trade Journals,
White papers, Government Agencies, Magazines, Newspapers, Trade associations, Books,
Industry Portals, Industry Associations and access to more than 500 paid databases.

Renub Research

Page 4 of 21

About Us
Renub Research

is a leading Market Research and Information Analysis Company with

centers at Noida India and Roswell USA. We have long-term experience especially in
international Business-to-Business Researches, Surveys, Business and Consulting. Throughout
the years we have acquired expertise in most market sectors, including Information Technology
(IT), Telecoms, Life Sciences, Medical & Pharmaceuticals, Financial Services (Banking,
Insurance, Reinsurance, M&A, etc.), Energy, Chemicals, Automotive, Retail, FMCG, Consumer
Goods, Logistics, Governmental, Social, and Others.
Our core team is comprised of an experienced people holding graduate, post graduate and
Ph.D. degrees in Finance, Marketing, Human Resource, Bio-Technology, Medicine, Information
Technology, Environmental Science and many more. Our research help make the business
decisions: on strategy, organization, operations, technology, mergers & acquisitions etc. We
support many blue chip companies by providing them findings and perspectives across a wide
range of markets. Our research reports offer a blend of information insight, analysis and
forecasting that is essential in todays ultra-competitive markets.

For more information on us or to view any of our sample work you can mail
us at info@renub.com

Renub Research

Page 5 of 21

Published
By

Renub Research
1st Floor,
C-86, Sector10
Noida 201301
Phone: +91-120-421-9822, 254-5750 (India)
+1-678-302-0700 (USA)
Fax : +91-120-424-9780
Email: info@renub.com
www.renub.com

Influenza Vaccines Market & Forecast Worldwide Analysis


Renub Research, 2014
Edition 1.0
All rights reserved. This publication is protected
by copyright. No part of it may be reproduced, stored
in a retrieval system or transmitted, in any form or by
any means, electronic mechanical, photocopying,
recording or otherwise without the prior written
permission of the publishers

Renub Research

Page 6 of 21

Table of Contents
1.

Executive Summary

2.

Worldwide Influenza Vaccines Market & Forecast


2.1

Worldwide Number of Persons Being Vaccinated with Seasonal Influenza Vaccines

2.2

Merger and Acquisition in Influenza Vaccines Market

3.

Worldwide Seasonal Influenza Vaccines Market & Forecast

4.

Worldwide Swine Flu (H1N1) Influenza Vaccines Market

5.

Worldwide Influenza Vaccines Market Share & Forecast


5.1

Segment wise Influenza Vaccines Market Share & Forecast

5.2

Countries wise Percentage of Persons Being Vaccinated with Seasonal Influenza Vaccines

Share & Forecast


5.3
6.

Countries wise Seasonal Influenza Vaccines Market Share & Forecast

Geographical Segmentation Seasonal Influenza Vaccines Market & Vaccination Coverage

(2008 2019)
6.1

United States

6.1.1

United States Number of Persons Being Vaccinated with Seasonal Influenza Vaccines

6.1.2

United States Seasonal Influenza Vaccines Market & Forecast

6.2

Japan

6.2.1

Japan Number of Persons Being Vaccinated with Seasonal Influenza Vaccines

6.2.2

Japan Seasonal Influenza Vaccines Market & Forecast

6.3

China

6.3.1

China Number of Persons Being Vaccinated with Seasonal Influenza Vaccines

6.3.2

China Seasonal Influenza Vaccines Market & Forecast

6.4

India

6.4.1

India Number of Persons Being Vaccinated with Seasonal Influenza Vaccines

6.4.2

India Seasonal Influenza Vaccines Market & Forecast

6.5

Brazil

6.5.1

Brazil Number of Persons Being Vaccinated with Seasonal Influenza Vaccines

6.5.2

Brazil Seasonal Influenza Vaccines Market & Forecast

6.6

Netherlands

Renub Research

Page 7 of 21

6.6.1

Netherlands Number of Persons Being Vaccinated with Seasonal Influenza Vaccines

6.6.2

Netherlands Seasonal Influenza Vaccines Market & Forecast

6.7

Germany

6.7.1

Germany Number of Persons Being Vaccinated with Seasonal Influenza Vaccines

6.7.2

Germany Seasonal Influenza Vaccines Market & Forecast

6.8

France

6.8.1

France Number of Persons Being Vaccinated with Seasonal Influenza Vaccines

6.8.2

France Seasonal Influenza Vaccines Market & Forecast

6.9

Italy

6.9.1

Italy Number of Persons Being Vaccinated with Seasonal Influenza Vaccines

6.9.2

Italy Seasonal Influenza Vaccines Market & Forecast

6.10

Spain

6.10.1

Spain Number of Persons Being Vaccinated with Seasonal Influenza Vaccines

6.10.2

Spain Seasonal Influenza Vaccines Market & Forecast

6.11

Denmark

6.11.1

Denmark Number of Persons Being Vaccinated with Seasonal Influenza Vaccines

6.11.2

Denmark Seasonal Influenza Vaccines Market & Forecast

6.12

Sweden

6.12.1

Sweden Number of Persons Being Vaccinated with Seasonal Influenza Vaccines

6.12.2

Sweden Seasonal Influenza Vaccines Market & Forecast

6.13

Portugal

6.13.1

Portugal Number of Persons Being Vaccinated with Seasonal Influenza Vaccines

6.13.2

Portugal Seasonal Influenza Vaccines Market & Forecast

6.14

Luxembourg

6.14.1

Luxembourg Number of Persons Being Vaccinated with Seasonal Influenza Vaccines

6.14.2

Luxembourg Seasonal Influenza Vaccines Market & Forecast

6.15

Lithuania

6.15.1

Lithuania Number of Persons Being Vaccinated with Seasonal Influenza Vaccines

6.15.2

Lithuania Seasonal Influenza Vaccines Market & Forecast

6.16

United Kingdom

6.16.1

United Kingdom Number of Persons Being Vaccinated with Seasonal Influenza Vaccines

6.16.2

United Kingdom Seasonal Influenza Vaccines Market & Forecast

6.17

Poland

6.17.1

Poland Number of Persons Being Vaccinated with Seasonal Influenza Vaccines

Renub Research

Page 8 of 21

6.17.2
6.18

Poland Seasonal Influenza Vaccines Market & Forecast

Norway

6.18.1

Norway Number of Persons Being Vaccinated with Seasonal Influenza Vaccines

6.18.2

Norway Seasonal Influenza Vaccines Market & Forecast

6.19

Romania

6.19.1

Romania Number of Persons Being Vaccinated with Seasonal Influenza Vaccines

6.19.2

Romania Seasonal Influenza Vaccines Market & Forecast

6.20

Estonia

6.20.1

Estonia Number of Persons Being Vaccinated with Seasonal Influenza Vaccines

6.20.2

Estonia Seasonal Influenza Vaccines Market & Forecast

6.21

Finland

6.21.1

Finland Number of Persons Being Vaccinated with Seasonal Influenza Vaccines

6.21.2

Finland Seasonal Influenza Vaccines Market & Forecast

6.22

Hungary

6.22.1

Hungary Number of Persons Being Vaccinated with Seasonal Influenza Vaccines

6.22.2

Hungary Seasonal Influenza Vaccines Market & Forecast

6.23

Ireland

6.23.1

Ireland Number of Persons Being Vaccinated with Seasonal Influenza Vaccines

6.23.2

Ireland Seasonal Influenza Vaccines Market & Forecast

6.24

Iceland

6.24.1

Iceland Number of Persons Being Vaccinated with Seasonal Influenza Vaccines

6.24.2

Iceland Seasonal Influenza Vaccines Market & Forecast

6.25

Latvia

6.25.1

Latvia Number of Persons Being Vaccinated with Seasonal Influenza Vaccines

6.25.2

Latvia Seasonal Influenza Vaccines Market & Forecast

6.26

Malta

6.26.1

Malta Number of Persons Being Vaccinated with Seasonal Influenza Vaccines

6.26.2

Malta Seasonal Influenza Vaccines Market & Forecast

6.27

Slovakia

6.27.1

Slovakia Number of Persons Being Vaccinated with Seasonal Influenza Vaccines

6.27.2

Slovakia Seasonal Influenza Vaccines Market & Forecast

6.28

Slovenia

6.28.1

Slovenia Number of Persons Being Vaccinated with Seasonal Influenza Vaccines

6.28.2

Slovenia Seasonal Influenza Vaccines Market & Forecast

Renub Research

Page 9 of 21

6.29

6.29.1

Australia Number of Persons Being Vaccinated with Seasonal Influenza Vaccines

6.29.2

Australia Seasonal Influenza Vaccines Market & Forecast

6.30

7.

8.

Australia

New Zealand

6.30.1

New Zealand Number of Persons Being Vaccinated with Seasonal Influenza Vaccines

6.30.2

New Zealand Seasonal Influenza Vaccines Market & Forecast

Worldwide Seasonal Influenza Vaccine Brand Sales & Forecast


7.1

Fluarix / Flulaval Sales Performance & Forecast

7.2

Afluria/Fluvax Sales Performance & Forecast

7.3

FluMist/Fluenz Sales Performance & Forecast

7.4

Influvac (Now Acquired by Abbott) Sales Performance & Forecast

7.5

Fluvirin / Flucelvax Sales Performance & Forecast

7.6

Fluzone Sales Performance & Forecast

Growth Drivers in the Influenza Vaccines Market


8.1

Transforming Vaccine Technologies

8.2

Continuous Focus on Effective Communication Strategies

8.3

Vaccines most Cost Effective Means of Disease Prevention

8.4

Scientific & Technological Breakthroughs

8.5

Promote Education, Training, & Information exchange on Seasonal Influenza & Vaccination in

European Countries
9.

Challenges for Influenza Vaccine Market


9.1

Obstacle to Best Possible use of Licensed Vaccines

9.1.1

Economic Obstacles

9.1.2

Technical Obstacles

9.1.3

Cultural Obstacles

9.2

Difficulty of Influenza Vaccine Development & Approval System

9.2.1

General Technical Barriers

9.2.2

Economic Barriers

9.2.3

Legal Barriers

9.2.4

Regulatory Barriers

9.3

Reducing the Timeline for Vaccine Development

Renub Research

Page 10 of 21

9.4

Problem Faced by Healthcare Workers in Immunization

Renub Research

Page 11 of 21

List of Figures

Figure 2-1: Worldwide Influenza Vaccines Market (Million US$), 2009 2013
Figure 2-2: Worldwide Forecast for Influenza Vaccines Market (Million US$), 2014 2019
Figure 2-3: Worldwide Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Million),
2009 2013
Figure 2-4: Worldwide Forecast for Number of Persons Being Vaccinated with Seasonal Influenza
Vaccines (Million), 2014 2019
Figure 3-1: Worldwide Seasonal Influenza Vaccines Market (Million US$), 2009 2013
Figure 3-2: Worldwide Forecast for Seasonal Influenza Vaccines Market (Million US$), 2014 2019
Figure 4-1: Worldwide Swine Flu (H1N1) Influenza Vaccines Market (Million US$), 2009 2011
Figure 5-1: Segment wise Influenza Vaccines Market Share (Percent), 2009 2013
Figure 5-2: Segment wise Forecast for Influenza Vaccines Market Share (Percent), 2014 2019
Figure 6-1: United States Number of Persons Being Vaccinated with Seasonal Influenza Vaccines
(Thousand), 2009 2013
Figure 6-2: United States Forecast for Number of Persons Being Vaccinated with Seasonal Influenza
Vaccines (Thousand), 2014 2019
Figure 6-3: United States Seasonal Influenza Vaccines Market (Million US$), 2009 2013
Figure 6-4: United States Forecast for Seasonal Influenza Vaccines Market (Million US$), 2014 2019
Figure 6-5: Japan Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand),
2008 2013
Figure 6-6: Japan Forecast for Number of Persons Being Vaccinated with Seasonal Influenza Vaccines
(Thousand), 2014 2019
Figure 6-7: Japan Seasonal Influenza Vaccines Market (Million US$), 2008 2013
Figure 6-8: Japan Forecast for Seasonal Influenza Vaccines Market (Million US$), 2014 2019
Figure 6-9: China Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand),
20082013
Figure 6-10: China Forecast for Number of Persons Being Vaccinated with Seasonal Influenza Vaccines
(Thousand), 2014 2019
Figure 6-11: China Seasonal Influenza Vaccines Market (Million US$), 2008 2013
Figure 6-12: China Forecast for Seasonal Influenza Vaccines Market (Million US$), 2014 2019
Figure 6-13: India Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand),
2008 2013
Figure 6-14: India Forecast for Number of Persons Being Vaccinated with Seasonal Influenza Vaccines
(Thousand), 2014 2019
Figure 6-15: India Seasonal Influenza Vaccines Market (Million US$), 2008 2013
Figure 6-16: India Forecast for Seasonal Influenza Vaccines Market (Million US$), 2014 2019
Renub Research

Page 12 of 21

Figure 6-17: Brazil Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand),
2008 2013
Figure 6-18: Brazil Forecast for Number of Persons Being Vaccinated with Seasonal Influenza Vaccines
(Thousand), 2014 2019
Figure 6-19: Brazil Seasonal Influenza Vaccines Market (Million US$), 2008 2013
Figure 6-20: Brazil Forecast for Seasonal Influenza Vaccines Market (Million US$), 2014 2019
Figure 6-21: Netherlands Number of Persons Being Vaccinated with Seasonal Influenza Vaccines
(Thousand), 2008 2013
Figure 6-22: Netherlands Forecast for Number of Persons Being Vaccinated with Seasonal Influenza
Vaccines (Thousand), 2014 2019
Figure 6-23: Netherlands Seasonal Influenza Vaccines Market (Million US$), 2008 2013
Figure 6-24: Netherlands Forecast for Seasonal Influenza Vaccines Market (Million US$), 2014 2019
Figure 6-25: Germany Number of Persons Being Vaccinated with Seasonal Influenza Vaccines
(Thousand), 2008 2013
Figure 6-26: Germany Forecast for Number of Persons Being Vaccinated with Seasonal Influenza
Vaccines (Thousand), 2014 2019
Figure 6-27: Germany Seasonal Influenza Vaccines Market (Million US$), 2008 2013
Figure 6-28: Germany Forecast for Seasonal Influenza Vaccines Market (Million US$), 2014 2019
Figure 6-29: France Number of Persons Being Vaccinated with Seasonal Influenza Vaccines
(Thousand), 2008 2013
Figure 6-30: France Forecast for Number of Persons Being Vaccinated with Seasonal Influenza Vaccines
(Thousand), 2014 2019
Figure 6-31: France Seasonal Influenza Vaccines Market (Million US$), 2008 2013
Figure 6-32: France Forecast for Seasonal Influenza Vaccines Market (Million US$), 2014 2019
Figure 6-33: Italy Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand),
2008 2013
Figure 6-34: Italy Forecast for Number of Persons Being Vaccinated with Seasonal Influenza Vaccines
(Thousand), 2014 2019
Figure 6-35: Italy Seasonal Influenza Vaccines Market (Million US$), 2008 2013
Figure 6-36: Italy Forecast for Seasonal Influenza Vaccines Market (Million US$), 2014 2019
Figure 6-37: Spain Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand),
2008 2013
Figure 6-38: Spain Forecast for Number of Persons Being Vaccinated with Seasonal Influenza Vaccines
(Thousand), 2014 2019
Figure 6-39: Spain Seasonal Influenza Vaccines Market (Million US$), 2008 2013
Figure 6-40: Spain Forecast for Seasonal Influenza Vaccines Market (Million US$), 2014 2019

Renub Research

Page 13 of 21

Figure 6-41: Denmark Number of Persons Being Vaccinated with Seasonal Influenza Vaccines
(Thousand), 2008 2013
Figure 6-42: Denmark Forecast for Number of Persons Being Vaccinated with Seasonal Influenza
Vaccines (Thousand), 2014 2019
Figure 6-43: Denmark Seasonal Influenza Vaccines Market (Million US$), 2008 2013
Figure 6-44: Denmark Forecast for Seasonal Influenza Vaccines Market (Million US$), 2014 2019
Figure 6-45: Sweden Number of Persons Being Vaccinated with Seasonal Influenza Vaccines
(Thousand), 2008 2013
Figure 6-46: Sweden Forecast for Number of Persons Being Vaccinated with Seasonal Influenza
Vaccines (Thousand), 2014 2019
Figure 6-47: Sweden Seasonal Influenza Vaccines Market (Million US$), 2008 2013
Figure 6-48: Sweden Forecast for Seasonal Influenza Vaccines Market (Million US$), 2014 2019
Figure 6-49: Portugal Number of Persons Being Vaccinated with Seasonal Influenza Vaccines
(Thousand), 2008 2013
Figure 6-50: Portugal Forecast for Number of Persons Being Vaccinated with Seasonal Influenza
Vaccines (Thousand), 2014 2019
Figure 6-51: Portugal Seasonal Influenza Vaccines Market (Million US$), 2008 2013
Figure 6-52: Portugal Forecast for Seasonal Influenza Vaccines Market (Million US$), 2014 2019
Figure 6-53: Luxembourg Number of Persons Being Vaccinated with Seasonal Influenza Vaccines
(Thousand), 2008 2013
Figure 6-54: Luxembourg Forecast for Number of Persons Being Vaccinated with Seasonal Influenza
Vaccines (Thousand), 2014 2019
Figure 6-55: Luxembourg Seasonal Influenza Vaccines Market (Million US$), 2008 2013
Figure 6-56: Luxembourg Forecast for Seasonal Influenza Vaccines Market (Million US$), 2014 2019
Figure 6-57: Lithuania Number of Persons Being Vaccinated with Seasonal Influenza Vaccines
(Thousand), 2008 2013
Figure 6-58: Lithuania Forecast for Number of Persons Being Vaccinated with Seasonal Influenza
Vaccines (Thousand), 2014 2019
Figure 6-59: Lithuania Seasonal Influenza Vaccines Market (Million US$), 2008 2013
Figure 6-60: Lithuania Forecast for Seasonal Influenza Vaccines Market (Million US$), 2014 2019
Figure 6-61: United Kingdom Number of Persons Being Vaccinated with Seasonal Influenza Vaccines
(Thousand), 2008 2013
Figure 6-62: United Kingdom Forecast for Number of Persons Being Vaccinated with Seasonal Influenza
Vaccines (Thousand), 2014 2019
Figure 6-63: United Kingdom Seasonal Influenza Vaccines Market (Million US$), 2008 2013
Figure 6-64: United Kingdom Forecast for Seasonal Influenza Vaccines Market (Million US$), 2014
2019

Renub Research

Page 14 of 21

Figure 6-65: Poland Number of Persons Being Vaccinated with Seasonal Influenza Vaccines
(Thousand), 2008 2013
Figure 6-66: Poland Forecast for Number of Persons Being Vaccinated with Seasonal Influenza Vaccines
(Thousand), 2014 2019
Figure 6-67: Poland Seasonal Influenza Vaccines Market (Million US$), 2008 2013
Figure 6-68: Poland Forecast for Seasonal Influenza Vaccines Market (Million US$), 2014 2019
Figure 6-69: Norway Number of Persons Being Vaccinated with Seasonal Influenza Vaccines
(Thousand), 2008 2013
Figure 6-70: Norway Forecast for Number of Persons Being Vaccinated with Seasonal Influenza
Vaccines (Thousand), 2014 2019
Figure 6-71: Norway Seasonal Influenza Vaccines Market (Million US$), 2008 2013
Figure 6-72: Norway Forecast for Seasonal Influenza Vaccines Market (Million US$), 2014 2019
Figure 6-73: Romania Number of Persons Being Vaccinated with Seasonal Influenza Vaccines
(Thousand), 2008 2013
Figure 6-74: Romania Forecast for Number of Persons Being Vaccinated with Seasonal Influenza
Vaccines (Thousand), 2014 2019
Figure 6-75: Romania Seasonal Influenza Vaccines Market (Million US$), 2008 2013
Figure 6-76: Romania Forecast for Seasonal Influenza Vaccines Market (Million US$), 2014 2019
Figure 6-77: Estonia Number of Persons Being Vaccinated with Seasonal Influenza Vaccines
(Thousand), 2008 2013
Figure 6-78: Estonia Forecast for Number of Persons Being Vaccinated with Seasonal Influenza
Vaccines (Thousand), 2014 2019
Figure 6-79: Estonia Seasonal Influenza Vaccines Market (Million US$), 2008 2013
Figure 6-80: Estonia Forecast for Seasonal Influenza Vaccines Market (Million US$), 2014 2019
Figure 6-81: Finland Number of Persons Being Vaccinated with Seasonal Influenza Vaccines
(Thousand), 2008 2013
Figure 6-82: Finland Forecast for Number of Persons Being Vaccinated with Seasonal Influenza
Vaccines (Thousand), 2014 2019
Figure 6-83: Finland Seasonal Influenza Vaccines Market (Million US$), 2008 2013
Figure 6-84: Finland Forecast for Seasonal Influenza Vaccines Market (Million US$), 2014 2019
Figure 6-85: Hungary Number of Persons Being Vaccinated with Seasonal Influenza Vaccines
(Thousand), 2008 2013
Figure 6-86: Hungary Forecast for Number of Persons Being Vaccinated with Seasonal Influenza
Vaccines (Thousand), 2014 2019
Figure 6-87: Hungary Seasonal Influenza Vaccines Market (Million US$), 2008 2013
Figure 6-88: Hungary Forecast for Seasonal Influenza Vaccines Market (Million US$), 2014 2019

Renub Research

Page 15 of 21

Figure 6-89: Ireland Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand),
20082013
Figure 6-90: Ireland Forecast for Number of Persons Being Vaccinated with Seasonal Influenza Vaccines
(Thousand), 2014 2019
Figure 6-91: Ireland Seasonal Influenza Vaccines Market (Million US$), 2008 2013
Figure 6-92: Ireland Forecast for Seasonal Influenza Vaccines Market (Million US$), 2014 2019
Figure 6-93: Iceland Number of Persons Being Vaccinated with Seasonal Influenza Vaccines
(Thousand), 2008 2013
Figure 6-94: Iceland Forecast for Number of Persons Being Vaccinated with Seasonal Influenza
Vaccines (Thousand), 2014 2019
Figure 6-95: Iceland Seasonal Influenza Vaccines Market (Million US$), 2008 2013
Figure 6-96: Iceland Forecast for Seasonal Influenza Vaccines Market (Million US$), 2014 2019
Figure 6-97: Latvia Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand),
2008 2013
Figure 6-98: Latvia Forecast for Number of Persons Being Vaccinated with Seasonal Influenza Vaccines
(Thousand), 2014 2019
Figure 6-99: Latvia Seasonal Influenza Vaccines Market (Million US$), 2008 2013
Figure 6-100: Latvia Forecast for Seasonal Influenza Vaccines Market (Million US$), 2014 2019
Figure 6-101: Malta Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand),
2008 2013
Figure 6-102: Malta Forecast for Number of Persons Being Vaccinated with Seasonal Influenza Vaccines
(Thousand), 2014 2019
Figure 6-103: Malta Seasonal Influenza Vaccines Market (Million US$), 2008 2013
Figure 6-104: Malta Forecast for Seasonal Influenza Vaccines Market (Million US$), 2014 2019
Figure 6-105: Slovakia Number of Persons Being Vaccinated with Seasonal Influenza Vaccines
(Thousand), 2008 2013
Figure 6-106: Slovakia Forecast for Number of Persons Being Vaccinated with Seasonal Influenza
Vaccines (Thousand), 2014 2019
Figure 6-107: Slovakia Seasonal Influenza Vaccines Market (Million US$), 2008 2013
Figure 6-108: Slovakia Forecast for Seasonal Influenza Vaccines Market (Million US$), 2014 2019
Figure 6-109: Slovenia Number of Persons Being Vaccinated with Seasonal Influenza Vaccines
(Thousand), 2008 2013
Figure 6-110: Slovenia Forecast for Number of Persons Being Vaccinated with Seasonal Influenza
Vaccines (Thousand), 2014 2019
Figure 6-111: Slovenia Seasonal Influenza Vaccines Market (Million US$), 2008 2013
Figure 6-112: Slovenia Forecast for Seasonal Influenza Vaccines Market (Million US$), 2014 2019

Renub Research

Page 16 of 21

Figure 6-113: Australia Number of Persons Being Vaccinated with Seasonal Influenza Vaccines
(Thousand), 2008 2013
Figure 6-114: Australia Forecast for Number of Persons Being Vaccinated with Seasonal Influenza
Vaccines (Thousand), 2014 2019
Figure 6-115: Australia Seasonal Influenza Vaccines Market (Million US$), 2008 2013
Figure 6-116: Australia Forecast for Seasonal Influenza Vaccines Market (Million US$), 2014 2019
Figure 6-117: New Zealand Number of Persons Being Vaccinated with Seasonal Influenza Vaccines
(Thousand), 2008 2013
Figure 6-118: New Zealand Forecast for Number of Persons Being Vaccinated with Seasonal Influenza
Vaccines (Thousand), 2014 2019
Figure 6-119: New Zealand Seasonal Influenza Vaccines Market (Million US$), 2008 2013
Figure 6-120: New Zealand Forecast for Seasonal Influenza Vaccines Market (Million US$), 2014 2019
Figure 7-1: Worldwide Fluarix / Flulaval Seasonal Influenza Vaccine Sales (Million US$), 2007 2013
Figure 7-2: Worldwide Forecast for Fluarix / Flulaval Seasonal Influenza Vaccine Sales (Million US$),
2014 2019
Figure 7-3: Worldwide Afluria/Fluvax Seasonal Influenza Vaccine Sales (Million US$), 2010 2013
Figure 7-4: Worldwide Forecast for Afluria/Fluvax Seasonal Influenza Vaccine Sales (Million US$), 2014
2019
Figure 7-5: Worldwide Flumist/ Fluenz Seasonal Infuenza Vaccine Sales (Million US$), 2009 2013
Figure 7-6: Worldwide Forecast for Flumist/Fluenz Seasonal Influenza Vaccine Sales (Million US$), 2014
2019
Figure 7-7: Worldwide Influvac Seasonal Infuenza Vaccine Sales (Million US$), 2007 2009
Figure 7-8: Worldwide Fluvirin/Flucelvax Seasonal Infuenza Vaccine Sales (Million US$), 2010 2013
Figure 7-9: Worldwide Forecast for Fluvirin/Flucelvax Seasonal Infuenza Vaccine Sales (Million US$),
2014 2019
Figure 7-10: Worldwide Fluzone Seasonal Infuenza Vaccine Sales (Million US$), 2009 2013
Figure 7-11: Worldwide Forecast for Fluzone Seasonal Infuenza Vaccine Sales (Million US$), 2014
2019

Renub Research

Page 17 of 21

List of Tables

Table 2-1: Worldwide Merger and Acquisition in Influenza Vaccines Market (Million US$), 2005 2011
Table 5-1: Countries wise Percentage of Persons Being Vaccinated with Seasonal Influenza Vaccines
Share (Percent), 2009 2013
Table 5-2: Countries wise Forecast for Percentage of Persons Being Vaccinated with Seasonal Influenza
Vaccines Share (Percent), 2014 2019
Table 5-3: Countries wise Seasonal Influenza Vaccines Market Share (Percent), 2009 2013
Table 5-4: Countries wise Forecast for Seasonal Influenza Vaccines Market Share (Percent), 2014
2019
Table 8-1: Improvement Strategies or Requirements the Joint Commission and the Projects
Collaborating Organizations
Table 8-2: Initiatives Taken in Communication, Education, Training & Information Exchange Related to
Seasonal Influenza in European Countries, 2009

Renub Research

Page 18 of 21

Order Form
Scan and e-mail this page to info@renub.com, alternatively one can also write the Contact
Information in an e-mail and mail it. Else you can also fax this form to +91-120-424-9780
Questions? Please call

+91-120-421-9822 (India),

+1-678-302-0700

(USA)

or

mail

info@renub.com

Format
Report Title: Influenza Vaccines Market & Forecast - Worldwide Analysis

Single User
(Email from Publisher)

Hard Copy
(Mail Delivery)

CD Rom
(Mail Delivery)

Global Site License


(Multiple User License)

US$ 1,490

US$ 1,640

US$ 1,590

US$ 2,490

For ordering this report: Three easy ways to place your order:
1) Order online by Credit Card (Visa, MasterCard, etc.):
http://www.renub.com/report/influenza-vaccines-market-forecast---worldwide-analysis-151
2) Order by Wire Transfer:
http://www.renub.com/report/wiretransfer.aspx?id=151&pid=1574

To pay by Wire Transfer, please, fill in your contact details in the form below:

Renub Research

Page 19 of 21

to

Bank Details
Account Name: Renub Research
A/C No.: 109102000023296
Name of Bank: IDBI Bank Ltd.
Swift Code: IBKLINBB010
Bank Address: 4th Floor
Indian Red Cross Building
1 Red Cross Road
Opposite Parliament Street
New Delhi 110001
India

Contact Information
First Name:

Last Name:

Email:
Job Title:
Company:
Address:
City:
Postal/Zip Code:
Country:
Phone:
Mobile:
Fax:
Report Format:
Your message:

Renub Research

Page 20 of 21

3) Order by Check
Please post the check accompanied by this form, to:
Company Address: Renub Research
1st Floor
C-86, Sector -10
Noida - 201301
Uttar Pradesh
India
Phone: +91-120-421-9822, 424-9780

For free Sample copy report or to view any of our sample work please contact us at
info@renub.com or call +91-120-421-9822 (India), +1-678-302-0700 (USA)

Follow Us
Facebook: http://www.facebook.com/pages/Renub-Research/233380966701090
LinkedIn: http://www.linkedin.com/company/renub-research
Twitter: http://twitter.com/RenubResearch

Renub Research

Page 21 of 21